Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asako Chiba

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Plos One|September 1, 2021
Modeling the effects of contact-tracing apps on the spread of the coronavirus disease: Mechanisms, conditions, and efficiencyAsako Chiba
Health & Place|July 18, 2021
The effectiveness of mobility control, shortening of restaurants' opening hours, and working from home on control of COVID-19 spread in JapanAsako Chiba
Methods in Molecular Biology (Clifton, N.J.)|April 8, 2014
Basic techniques for studies of iNKT cells and MAIT cellsAsako Chiba, Sachiko Miyake
Modern Rheumatology|January 7, 2014
Potential of targeting natural killer T cells for the treatment of autoimmune diseasesSachiko Miyake, Asako Chiba, Takashi Yamamura
Frontiers in Immunology|June 27, 2018
Mucosal-Associated Invariant T Cells in Autoimmune DiseasesAsako Chiba, Goh Murayama, Sachiko Miyake
International Immunology|September 11, 2021
Characteristics of mucosal-associated invariant T cells and their roles in immune diseasesAsako Chiba, Goh Murayama, Sachiko Miyake
The Journal of Clinical Investigation|June 3, 2004
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cellsShinji Oki, Asako Chiba, Takashi Yamamura, et al.
Frontiers in Immunology|August 1, 2025
Myeloid cells as IFNα producers in systemic lupus erythematosusTaiga Kuga, Asako Chiba, Goh Murayama, et al.
Frontiers in Public Health|July 10, 2026
COVID-19 symptom duration: evidence from a survey of infected workers in TokyoAsako Chiba, Taisuke Nakata, Naohisa Shobako, et al.
Scientific Reports|July 23, 2024
COVID-19 risk perceptions in Japan: a cross-sectional studyAsako Chiba, Taisuke Nakata, Thuy Linh Nguyen, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Plos One|September 1, 2021
Modeling the effects of contact-tracing apps on the spread of the coronavirus disease: Mechanisms, conditions, and efficiencyAsako Chiba
Health & Place|July 18, 2021
The effectiveness of mobility control, shortening of restaurants' opening hours, and working from home on control of COVID-19 spread in JapanAsako Chiba
Methods in Molecular Biology (Clifton, N.J.)|April 8, 2014
Basic techniques for studies of iNKT cells and MAIT cellsAsako Chiba, Sachiko Miyake
Modern Rheumatology|January 7, 2014
Potential of targeting natural killer T cells for the treatment of autoimmune diseasesSachiko Miyake, Asako Chiba, Takashi Yamamura
Frontiers in Immunology|June 27, 2018
Mucosal-Associated Invariant T Cells in Autoimmune DiseasesAsako Chiba, Goh Murayama, Sachiko Miyake
International Immunology|September 11, 2021
Characteristics of mucosal-associated invariant T cells and their roles in immune diseasesAsako Chiba, Goh Murayama, Sachiko Miyake
The Journal of Clinical Investigation|June 3, 2004
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cellsShinji Oki, Asako Chiba, Takashi Yamamura, et al.
Frontiers in Immunology|August 1, 2025
Myeloid cells as IFNα producers in systemic lupus erythematosusTaiga Kuga, Asako Chiba, Goh Murayama, et al.
Frontiers in Public Health|July 10, 2026
COVID-19 symptom duration: evidence from a survey of infected workers in TokyoAsako Chiba, Taisuke Nakata, Naohisa Shobako, et al.
Scientific Reports|July 23, 2024
COVID-19 risk perceptions in Japan: a cross-sectional studyAsako Chiba, Taisuke Nakata, Thuy Linh Nguyen, et al.
Pageof 6